|View printer-friendly version|
|September 06, 2005 11:43 a.m.|
|Teva and Barr Announce Launch of Generic Allegra® Tablets by Teva Under Agreement With Barr|
Woodcliff Lake, NJ, September 6, 2005 - Barr Pharmaceuticals, Inc. (NYSE: BRL) and Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced that they have entered into an agreement for the launch of Fexofenadine Hydrochloride 30 mg, 60 mg and 180 mg Tablets, the generic versions of Aventis Pharmaceuticals' Allegra® Tablets. Allegra tablets had annual sales of approximately $1.4 billion, based on IMS data for the twelve months ended June 2005.